The U.S. Food and Drug Administration has granted 510(k) clearance to Ivera Medical Corporation, allowing it to market its Curos™ Port Protector. The product decontaminates needle-less intravenous access ports, preventing touch and airborne contamination. Designed to lessen patients’ exposure to the risks of bloodstream infections acquired from hospitals, the Curos Port Protector facilitates infection control. Such infections lengthen a patient’s stay in hospital and can be dangerous too. Thus, the device can be really useful in improving patient care through promotion among healthcare professionals.